18 March 2022 - Deborah Wilkes
Premium
Perrigo has switched the allergy medicine Nasonex (mometasone furoate monohydrate) from prescription-to-OTC status in the US. Nasonex 24HR Allergy joins a small number of brands marketed by Perrigo in the US where it specialises in store-brand products.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.